Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2

The COVID-19 pandemic accelerated the development of decentralized clinical trials (DCT). DCT’s are an important and pragmatic method for assessing health outcomes yet comprise only a minority of clinical trials, and few published methodologies exist. In this report, we detail the operational compon...

Descripción completa

Detalles Bibliográficos
Autores principales: Avula, Nandini, Kakach, Dustin, Tignanelli, Christopher J., Liebovitz, David M., Nicklas, Jacinda M., Cohen, Kenneth, Puskarich, Michael A., Belani, Hrishikesh K., Buse, John B., Klatt, Nichole R., Anderson, Blake, Karger, Amy B., Hartman, Katrina M., Patel, Barkha, Fenno, Sarah L., Reddy, Neha V., Erickson, Spencer M., Boulware, David R., Murray, Thomas A., Bramante, Carolyn T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Special Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685265/
https://www.ncbi.nlm.nih.gov/pubmed/38033705
http://dx.doi.org/10.1017/cts.2023.668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685265/
https://www.ncbi.nlm.nih.gov/pubmed/38033705
http://dx.doi.org/10.1017/cts.2023.668

Ejemplares similares